Healthcare & Life Sciences
Skye Bioscience, Inc
United Statesskyebioscience.com/
Skye Bioscience, Inc is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Skye Bioscience, Inc
Skye Bioscience, Inc is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Skye Bioscience is a biotechnology company developing next-generation drugs to treat obesity and other metabolic diseases by modulating G-protein coupled receptors. Its pipeline includes nimacimab, a CB1 receptor inhibitor aimed at reducing excess body fat and improving metabolic health.
Explore Skye Bioscience, Inc's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.